Your browser doesn't support javascript.
loading
The immune response to influenza in older humans: beyond immune senescence.
McElhaney, Janet E; Verschoor, Chris P; Andrew, Melissa K; Haynes, Laura; Kuchel, George A; Pawelec, Graham.
  • McElhaney JE; 1Health Sciences North Research Institute, 41 Ramsey Lake Road, Sudbury, ON P3E 5J1 Canada.
  • Verschoor CP; 1Health Sciences North Research Institute, 41 Ramsey Lake Road, Sudbury, ON P3E 5J1 Canada.
  • Andrew MK; 2Department of Medicine and Canadian Centre for Vaccinology, Dalhousie University, Halifax, NS Canada.
  • Haynes L; 3University of Connecticut Center on Aging, UConn Health Center, Farmington, CT USA.
  • Kuchel GA; 3University of Connecticut Center on Aging, UConn Health Center, Farmington, CT USA.
  • Pawelec G; 1Health Sciences North Research Institute, 41 Ramsey Lake Road, Sudbury, ON P3E 5J1 Canada.
Immun Ageing ; 17: 10, 2020.
Article en En | MEDLINE | ID: mdl-32399058
ABSTRACT
Despite widespread influenza vaccination programs, influenza remains a major cause of morbidity and mortality in older adults. Age-related changes in multiple aspects of the adaptive immune response to influenza have been well-documented including a decline in antibody responses to influenza vaccination and changes in the cell-mediated response associated with immune senescence. This review will focus on T cell responses to influenza and influenza vaccination in older adults, and how increasing frailty or coexistence of multiple (≥2) chronic conditions contributes to the loss of vaccine effectiveness for the prevention of hospitalization. Further, dysregulation of the production of pro- and anti-inflammatory mediators contributes to a decline in the generation of an effective CD8 T cell response needed to clear influenza virus from the lungs. Current influenza vaccines provide only a weak stimulus to this arm of the adaptive immune response and rely on re-stimulation of CD8 T cell memory related to prior exposure to influenza virus. Efforts to improve vaccine effectiveness in older adults will be fruitless until CD8 responses take center stage.
Palabras clave